000137575 001__ 137575
000137575 005__ 20240321220256.0
000137575 0247_ $$2doi$$a10.1212/WNL.0000000000000470
000137575 0247_ $$2pmid$$apmid:24808014
000137575 0247_ $$2ISSN$$a0028-3878
000137575 0247_ $$2ISSN$$a1526-632X
000137575 0247_ $$2altmetric$$aaltmetric:2335375
000137575 037__ $$aDZNE-2020-03897
000137575 041__ $$aEnglish
000137575 082__ $$a610
000137575 1001_ $$0P:(DE-HGF)0$$aSzentkirályi, András$$b0$$eCorresponding author
000137575 245__ $$aMultimorbidity and the risk of restless legs syndrome in 2 prospective cohort studies.
000137575 260__ $$a[S.l.]$$bOvid$$c2014
000137575 264_1 $$2Crossref$$3online$$bOvid Technologies (Wolters Kluwer Health)$$c2014-05-07
000137575 264_1 $$2Crossref$$3print$$bOvid Technologies (Wolters Kluwer Health)$$c2014-06-03
000137575 3367_ $$2DRIVER$$aarticle
000137575 3367_ $$2DataCite$$aOutput Types/Journal article
000137575 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1585913191_28976
000137575 3367_ $$2BibTeX$$aARTICLE
000137575 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000137575 3367_ $$00$$2EndNote$$aJournal Article
000137575 520__ $$aOur aim was to evaluate the association between the cumulative effect of comorbidity and the risk of restless legs syndrome (RLS) in 2 population-based German cohort studies.The Dortmund Health Study (DHS) (n = 1,312; median follow-up time: 2.1 years) and the Study of Health in Pomerania (SHIP) (n = 4,308; median follow-up time: 5.0 years) were used for the analyses. RLS was assessed at baseline and follow-up according to the RLS minimal criteria. A comorbidity index was calculated as a sum of the following conditions: diabetes, hypertension, myocardial infarction, obesity, stroke, cancer, renal disease, anemia, depression, thyroid disease, and migraine. The relationship between comorbidity and incident RLS was analyzed with multivariate logistic regression models.An increase in the number of comorbid conditions at baseline predicted prevalent RLS (DHS: trend odds ratio [OR] = 1.24, 95% confidence interval [CI] 0.99-1.56; SHIP: trend OR = 1.34, 95% CI 1.18-1.52) and incident RLS (DHS: trend OR = 1.32, 95% CI 1.04-1.68; SHIP: trend OR = 1.59, 95% CI 1.37-1.85) after adjustment for several covariates. The ORs for incident RLS associated with 3 or more comorbid diseases (DHS: OR = 2.51, 95% CI 1.18-5.34; SHIP: OR = 4.30, 95% CI 2.60-7.11) were higher than the ORs for any single disease.Multimorbidity was a strong risk factor for RLS in these 2 population-based cohort studies. The results support the hypothesis that cumulative disease burden is more important than the presence of a specific single disease in the pathophysiology of RLS.
000137575 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000137575 588__ $$aDataset connected to CrossRef, PubMed,
000137575 650_2 $$2MeSH$$aAdult
000137575 650_2 $$2MeSH$$aAged
000137575 650_2 $$2MeSH$$aComorbidity
000137575 650_2 $$2MeSH$$aFemale
000137575 650_2 $$2MeSH$$aGermany: epidemiology
000137575 650_2 $$2MeSH$$aHumans
000137575 650_2 $$2MeSH$$aMale
000137575 650_2 $$2MeSH$$aMiddle Aged
000137575 650_2 $$2MeSH$$aPrevalence
000137575 650_2 $$2MeSH$$aProspective Studies
000137575 650_2 $$2MeSH$$aRestless Legs Syndrome: epidemiology
000137575 650_2 $$2MeSH$$aRisk Factors
000137575 7001_ $$0P:(DE-HGF)0$$aVölzke, Henry$$b1
000137575 7001_ $$0P:(DE-2719)2000040$$aHoffmann, Wolfgang$$b2$$udzne
000137575 7001_ $$0P:(DE-HGF)0$$aTrenkwalder, Claudia$$b3
000137575 7001_ $$0P:(DE-HGF)0$$aBerger, Klaus$$b4
000137575 77318 $$2Crossref$$3journal-article$$a10.1212/wnl.0000000000000470$$b : Ovid Technologies (Wolters Kluwer Health), 2014-05-07$$n22$$p2026-2033$$tNeurology$$v82$$x0028-3878$$y2014
000137575 773__ $$0PERI:(DE-600)1491874-2$$a10.1212/WNL.0000000000000470$$gVol. 82, no. 22, p. 2026 - 2033$$n22$$p2026-2033$$q82:22<2026 - 2033$$tNeurology$$v82$$x0028-3878$$y2014
000137575 909CO $$ooai:pub.dzne.de:137575$$pVDB
000137575 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000040$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000137575 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$aDE-HGF$$bForschungsbereich Gesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000137575 9141_ $$y2014
000137575 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000137575 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROLOGY : 2017
000137575 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000137575 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000137575 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000137575 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000137575 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000137575 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000137575 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000137575 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000137575 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000137575 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000137575 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000137575 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROLOGY : 2017
000137575 9201_ $$0I:(DE-2719)1510600$$kTranslational Health Care Research$$lTranslational Health Care Research$$x0
000137575 980__ $$ajournal
000137575 980__ $$aVDB
000137575 980__ $$aI:(DE-2719)1510600
000137575 980__ $$aUNRESTRICTED